Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Dr Reddy's Laboratories Ltd (ADR) before investing.

In this article, we go over a few key elements for understanding Dr Reddy's Laboratories Ltd (ADR)’s stock price such as:

• Dr Reddy's Laboratories Ltd (ADR)’s current stock price and volume
• Why Dr Reddy's Laboratories Ltd (ADR)’s stock price changed recently
• Upgrades and downgrades for RDY from analysts
• RDY’s stock price momentum as measured by its relative strength

About Dr Reddy's Laboratories Ltd (ADR) (RDY)

Before we jump into Dr Reddy's Laboratories Ltd (ADR)’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Dr. Reddy’s Laboratories Limited is an India-based global pharmaceutical company. The Company offers a portfolio of products and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC). Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. The Company’s segments include Pharmaceutical Services and Active Ingredients, Global Generics, and Others. The Pharmaceutical Services and Active Ingredients segment primarily consists of the Company’s business of manufacturing and marketing APIs and intermediates. The Global Generics segment consists of the Company’s business of manufacturing and marketing prescription and OTC finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics).

Want to learn more about Dr Reddy's Laboratories Ltd (ADR)’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Dr Reddy's Laboratories Ltd (ADR).

Dr Reddy's Laboratories Ltd (ADR)’s Stock Price as of Market Close

As of June 27, 2024, 4:00 PM, CST, Dr Reddy's Laboratories Ltd (ADR)’s stock price was $75.40.

Dr Reddy's Laboratories Ltd (ADR) is up 4.68% from its previous closing price of $72.03.

During the last market session, Dr Reddy's Laboratories Ltd (ADR)’s stock traded between $71.55 and $72.07. Currently, there are 166.52 million shares of Dr Reddy's Laboratories Ltd (ADR) stock available for purchase.

Dr Reddy's Laboratories Ltd (ADR)’s price-earnings (P/E) ratio is currently at 18.0, which is low compared to the Pharmaceuticals industry median of 21.8. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Dr Reddy's Laboratories Ltd (ADR) Stock Price History

Dr Reddy's Laboratories Ltd (ADR)’s (RDY) price is currently up 9.78% so far this month.

During the month of June, Dr Reddy's Laboratories Ltd (ADR)’s stock price has reached a high of $75.80 and a low of $68.43.

Over the last year, Dr Reddy's Laboratories Ltd (ADR) has hit prices as high as $77.72 and as low as $61.26. Year to date, Dr Reddy's Laboratories Ltd (ADR)’s stock is up 45.7%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Dr Reddy's Laboratories Ltd (ADR) Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of June 26, 2024,, no analysts have changed their rating of Dr Reddy's Laboratories Ltd (ADR)’s stock over the last month.

Additionally, you'll want to evaluate Dr Reddy's Laboratories Ltd (ADR)’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Dr Reddy's Laboratories Ltd (ADR)’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Dr Reddy's Laboratories Ltd (ADR)’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Dr Reddy's Laboratories Ltd (ADR) (RDY) by visiting AAII Stock Evaluator.

Relative Price Strength of Dr Reddy's Laboratories Ltd (ADR)

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of June 26, 2024, Dr Reddy's Laboratories Ltd (ADR) has a weighted four-quarter relative price strength of -1.97%, which translates to a Momentum Score of 67 and is considered to be Strong.

Want to learn more about how Dr Reddy's Laboratories Ltd (ADR) is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Dr Reddy's Laboratories Ltd (ADR) Stock Price: Bottom Line

As of June 27, 2024, Dr Reddy's Laboratories Ltd (ADR)’s stock price is $75.40, which is up 4.68% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Dr Reddy's Laboratories Ltd (ADR) stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.